Key result
Effective perioperative blood pressure control with clevidipine decreased hospital costs by 7%, averaging a $394 reduction per patient compared with other IV antihypertensives.
Why the study?
Does effective perioperative blood pressure control with clevidipine reduce hospital costs in cardiac surgery patients requiring IV antihypertensives?
Does effective perioperative blood pressure control with clevidipine reduce hospital costs in cardiac surgery patients requiring IV antihypertensives?
Effect estimate: 7% decrease
Effective perioperative blood pressure control with clevidipine in cardiac surgery patients is associated with reduced total hospital costs compared to other IV antihypertensives.
No takes yet. Share an insight, caveat, or question.
Clevidipine may reduce costs in cardiac surgery; leaves open randomized confirmation of net benefit versus alternatives.
Getsios et al. (2013) studied Perioperative hypertension in cardiac surgery. Clevidipine vs. Other IV antihypertensives (sodium nitroprusside, nitroglycerin, nicardipine) was evaluated on Total hospitalization costs (7% decrease). Effective perioperative blood pressure control with clevidipine decreased hospital costs by 7%, averaging a $394 reduction per patient compared with other IV antihypertensives.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: